Biocon and Quark Pharmaceuticals,a leader in the discovery and develop...
Thalassemia is a disorder of abnormal formation of hemoglobin and ther...
According to a new market research report published by MarketsandMarke...
The resulting merger will generate revenues close to $406 million and ...
ChemoCentryx's CCX168, an orally administered small molecule in develo...
More than 20 tumor types are being treated with one or more of the 70 ...
Horizon Pharma and Hyperion Therapeutics have announced that they have...
New Page 1 Biotech's New Wave of Entrepreneurs A YEAR L...
The event is being organized to showcase the ongoing teaching and rese...
The National Biotechnology Development Strategy 2015-20 was unveiled o...
Come July 3rd, Chennai will witness a large gathering of delegates rep...
In the wake of growing harassment faced by entrepreneurs in the field ...
Six out of the 100 companies listed were in the Life Sciences industry...
Pharma Major Lupin has announced that its Japanese subsidiary Kyowa Ph...
Aurobindo Pharma is pleased to announce that the company has received ...
Plasma proteins matter a lot for India Plasma proteins m...
Jubilant Life Sciences informed BSE that consequent to appointment of ...
Daiichi Sankyo Company, Limited (hereafter Daiichi Sankyo) has announc...
